Jamie Reed – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Jamie Reed on 2016-06-07.

To ask the Secretary of State for Health, how much Government funding has been allocated to the research of Type 1 Diabetes in each of the last 10 years.

George Freeman

The information requested is not available.

The Department’s National Institute for Health Research (NIHR) was established in 2006 to increase the volume of applied health research for the benefit of patients and the public, drive faster translation of basic science discoveries into tangible benefits for patients and the economy, and develop and support the people who conduct and contribute to applied health research. The NIHR spent £30.8 million on research relating to metabolic and endocrine disease in 2014/15 (the latest available figure). Most of this investment (£24.4 million in 2014/15) is in infrastructure for research in metabolic and endocrine disease where spend on specific disease areas such as type 1 diabetes cannot be separated from total infrastructure expenditure. This infrastructure including NIHR biomedical research centres and the NIHR Clinical Research Network.

The NIHR funds a wide range of research relating to type 1 diabetes and in 2014/15 the NIHR CRN supported 49 studies in this disease area.

The NIHR Efficacy and Mechanism Evaluation programme is currently seeking to commission research on immunotherapy for type 1 diabetes.